No, you should not take venlafaxine and linezolid together—the FDA classifies this combination as contraindicated, meaning the risks outweigh any potential benefits. Taking these two medications simultaneously can trigger serotonin syndrome, a potentially life-threatening condition that requires immediate medical attention. If you have been prescribed both medications or are considering using them together, contact your pharmacist or doctor before taking either drug.
The FDA drug labeling for venlafaxine explicitly warns against concomitant use with linezolid. The contraindication stems from linezolid's monoamine oxidase inhibitor (MAOI) activity—a pharmacological property that was not the drug's original intended mechanism when it was developed as an antibiotic, but one that has significant clinical implications for drug safety.
According to FDA data sourced from the National Library of Medicine, the interaction severity is listed as "contraindicated," placing it in the highest risk category. This classification means that healthcare providers should avoid combining these drugs except in extraordinary circumstances where the benefits demonstrably outweigh the serious risks, and only with intensive monitoring.
To understand why venlafaxine and linezolid cannot be safely combined, you need to know what each drug does in your brain and body.
Venlafaxine's mechanism: Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by blocking the reabsorption (reuptake) of two neurotransmitters—serotonin and norepinephrine—at nerve endings in the brain. When these neurotransmitters are not reabsorbed, they accumulate in the synapse (the gap between nerve cells), increasing their activity and improving mood.
Linezolid's mechanism: Linezolid is a broad-spectrum antibiotic used to treat serious gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). Its primary mechanism is inhibiting bacterial protein synthesis. However, linezolid also possesses weak monoamine oxidase inhibitor (MAOI) activity. This means it inhibits the enzyme monoamine oxidase, which normally breaks down serotonin, norepinephrine, and dopamine in the brain and body.
The collision: When you take venlafaxine (which increases serotonin levels by blocking reuptake) and linezolid (which increases serotonin levels by preventing its breakdown via MAOI inhibition) at the same time, serotonin accumulates to dangerous levels. This excessive serotonin activity—particularly in the central nervous system—produces a condition called serotonin syndrome.
Serotonin syndrome occurs when serotonin levels exceed the brain's ability to regulate them normally. The result is a cascade of neurological, muscular, and autonomic symptoms that can progress from mild to severe within hours. Unlike some drug interactions that cause gradual problems, serotonin syndrome can develop rapidly and requires emergency care.
While the contraindication applies broadly, certain patient populations face heightened risk:
Consider the case of Patricia, a 58-year-old woman who has been taking venlafaxine 225 mg daily for major depressive disorder. She develops a painful infected wound from minor surgery that cultures positive for methicillin-resistant Staphylococcus aureus (MRSA). Her infectious disease physician prescribes linezolid 600 mg twice daily, the standard dose for serious MRSA infections.
Patricia's doctor does not catch the interaction during their appointment. She fills the linezolid prescription and takes her first dose that evening along with her regular venlafaxine. Within 6 to 12 hours, Patricia develops tremors in her hands, feels unusually agitated, and experiences muscle rigidity in her legs. Her temperature rises to 101.5°F, and she becomes confused about why she feels so strange.
Patricia calls her daughter, who recognizes something is seriously wrong and takes her to the emergency room. In the ED, Patricia is diagnosed with serotonin syndrome. Her medications are reviewed, and both venlafaxine and linezolid are identified as the culprits. She is treated with benzodiazepines to control agitation and muscle rigidity, given intravenous fluids, and linezolid is stopped immediately. Venlafaxine is also discontinued. Patricia recovers over 24 to 48 hours with supportive care.
The alternative management: Patricia's infectious disease physician should have communicated with her psychiatrist before prescribing linezolid. A safer approach would have been to choose an alternative antibiotic—such as vancomycin or doxycycline (depending on the infection site and organism sensitivities)—that does not have MAOI properties. If linezolid was absolutely necessary, venlafaxine would have needed to be discontinued at least 1 to 2 weeks before starting linezolid (to allow the drug to clear from her system), and Patricia would have required psychiatric support for her depression during that gap. This case illustrates why communication between all of your prescribers is essential.
Consider James, a 71-year-old man on venlafaxine 150 mg daily for generalized anxiety disorder. He develops a skin infection (cellulitis) that his primary care doctor suspects may be caused by MRSA, given a recent hospitalization. The primary care doctor prescribes linezolid without reviewing James's full medication list—an oversight that happens more often than patients realize, especially when electronic health records are incomplete or not fully integrated across healthcare systems.
James picks up linezolid from the pharmacy and starts it that day. By day 2, he notices he feels "wired," sweaty, and his heart is racing. He initially attributes it to anxiety, but the symptoms worsen. He develops a mild headache and notices his legs feel stiff. On day 3, his daughter visits and finds him confused and disoriented. She calls 911.
In the hospital, James is diagnosed with serotonin syndrome. He also develops a secondary complication: his elevated body temperature and dehydration from the syndrome, combined with his age, trigger acute kidney injury. He requires ICU-level care with aggressive fluid resuscitation, cooling measures, and cessation of both offending medications. He recovers but requires several days of hospitalization and careful monitoring.
The preventive step: James's pharmacist could have caught this interaction. When James went to fill his linezolid prescription, a pharmacist reviewing his profile would have seen venlafaxine and flagged the contraindication immediately, contacting his prescriber before James left the pharmacy. This is why checking with your pharmacist before filling any new prescription is a critical safety step—especially if you're on an antidepressant.
Step 1: Inform your doctor and pharmacist immediately. Before you fill a linezolid prescription, tell your pharmacist you are taking venlafaxine. Do not assume your doctor knows all your medications—electronic records are sometimes incomplete, and prescribers can miss interactions despite their best efforts. Your pharmacist is trained to catch these interactions and will contact your doctor if needed.
Step 2: Do not stop either medication on your own. If you are already taking both medications together, do not abruptly stop venlafaxine or linezolid without medical guidance. Stopping venlafaxine suddenly can cause withdrawal symptoms, and stopping linezolid prematurely may allow your infection to worsen. Call your doctor or pharmacist immediately and describe your situation.
Step 3: Ask about alternatives. If you need an antibiotic for a bacterial infection while on venlafaxine, several safer options exist depending on your infection type:
Your prescriber can choose the best alternative based on your specific infection, allergy history, kidney function, and other factors.
Step 4: If linezolid is truly necessary, venlafaxine must be stopped. In rare cases where linezolid is the only appropriate antibiotic (certain vancomycin-resistant enterococcal infections, for instance), your psychiatrist and infectious disease specialist may agree that venlafaxine must be discontinued. This requires careful planning: you should stop venlafaxine at least 1 to 2 weeks before starting linezolid to allow the drug to clear from your system. During this gap, your psychiatrist may provide alternative short-term mental health support (such as a different medication class, therapy, or hospitalization if needed) to manage your depression or anxiety.
Contact your doctor or call 911 immediately if you experience any of the following while taking venlafaxine and linezolid—these are signs of serotonin syndrome:
Serotonin syndrome can develop within 6 to 24 hours of taking both medications, though some cases develop more slowly. Do not wait to see if symptoms resolve on their own—early recognition and medical intervention can prevent serious complications.
Even if symptoms are mild, call your pharmacist or doctor during business hours if you notice:
These early signs warrant immediate professional evaluation to determine whether you can safely continue the medication combination.
If you are taking venlafaxine, you should be aware of other serious interactions. Learn more about related drug interactions:
If you are taking venlafaxine or have been prescribed linezolid, or if you are considering either medication, do not rely on memory or partial information from a single doctor. The best way to catch dangerous drug interactions before they happen is to use a comprehensive drug interaction checker that has access to the complete FDA labeling database. Visit checkdruginteractions.com and enter all of your current medications—including over-the-counter drugs, supplements, and herbal products. Our tool, powered by over 250,000 FDA drug labels from openFDA and the NIH National Library of Medicine, will instantly identify any serious interactions and provide you with the same FDA-level data your pharmacist uses. Taking two minutes to check now could prevent a hospital visit. Your health is too important to leave to chance.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.